NasdaqCM - Delayed Quote • USD
Curis, Inc. (CRIS)
At close: April 25 at 4:00 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 6 | 6 |
Avg. Estimate | -2.12 | -1.87 | -6.2 | -5.12 |
Low Estimate | -2.19 | -2.21 | -8.88 | -8.81 |
High Estimate | -2.08 | -0.78 | -3.29 | -2.56 |
Year Ago EPS | -2.4 | -2.4 | -8.96 | -6.2 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | 2.4M | 2.44M | 10.33M | 10.76M |
Low Estimate | 2.2M | 2.17M | 9.9M | 10.02M |
High Estimate | 2.9M | 2.9M | 11.7M | 12.1M |
Year Ago Sales | 2.3M | 2.2M | 10.02M | 10.33M |
Sales Growth (year/est) | 4.50% | 11.10% | 3.10% | 4.20% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | -2.08 | -2.36 | -2.33 | -2.11 |
EPS Actual | -2.4 | -2.4 | -2.13 | -2.03 |
Difference | -0.32 | -0.04 | 0.2 | 0.08 |
Surprise % | -15.40% | -1.70% | 8.60% | 3.80% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | -2.12 | -1.87 | -6.2 | -5.12 |
7 Days Ago | -2.12 | -1.87 | -6.2 | -5.12 |
30 Days Ago | -2.12 | -1.87 | -5.7 | -5.03 |
60 Days Ago | -2.12 | -1.87 | -5.71 | -4.75 |
90 Days Ago | -2.09 | -2.05 | -5.69 | -5.19 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | CRIS | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | 11.70% | -- | -- | 2.60% |
Next Qtr. | 22.10% | -- | -- | 13.40% |
Current Year | 30.80% | -- | -- | 5.20% |
Next Year | 17.40% | -- | -- | 13.30% |
Next 5 Years (per annum) | -- | -- | -- | 11.11% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Maintains | HC Wainwright & Co.: Buy to Buy | 2/9/2024 |
Initiated | Truist Securities: Buy | 11/17/2023 |
Related Tickers
RIGL Rigel Pharmaceuticals, Inc.
1.1000
-2.22%
ADCT ADC Therapeutics SA
4.4400
-7.11%
AFMD Affimed N.V.
4.8800
0.00%
MREO Mereo BioPharma Group plc
2.8100
+1.08%
MRSN Mersana Therapeutics, Inc.
2.8500
-1.04%
KPTI Karyopharm Therapeutics Inc.
1.0600
-2.75%
COCP Cocrystal Pharma, Inc.
1.5100
+0.67%
BCEL Atreca, Inc.
0.0855
+0.59%
ALXO ALX Oncology Holdings Inc.
16.87
+4.01%
SWTX SpringWorks Therapeutics, Inc.
44.20
+1.89%